Provide your email address to receive our printable guide outlining emergency symptoms and actions.
Additionally, enjoy our monthly Allergy Outlook email, delivering the latest news, updates, and resources directly to your inbox.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a lower-dose version of the adrenaline nasal spray, EURneffy®, for the emergency treatment of serious allergic reactions (anaphylaxis) in children aged four years and over. This adrenaline device option is
[…]
The announcement that Natasha’s Foundation has launched Natasha’s Prize – a groundbreaking £10 million fund dedicated to research into preventing allergies – has been hugely encouraging for the allergy community. As a charity supporting people living with serious allergies, Anaphylaxis UK warmly
[…]
The National Institute for Health and Care Excellence (NICE) has published updated guidance on the assessment and referral of people following emergency treatment for anaphylaxis. This new guideline replaces NICE guideline CG134 (December 2011). The update aims to improve the
[…]